Reuters logo
BRIEF-Allergan reports qtrly loss per share from continuing operations of $7.85
May 9, 2017 / 11:28 AM / 5 months ago

BRIEF-Allergan reports qtrly loss per share from continuing operations of $7.85

May 9 (Reuters) - Allergan Plc:

* Allergan reports solid start to 2017 with 5 pct increase in first quarter GAAP net revenues to $3.6 billion

* Q1 non-GAAP earnings per share $3.35

* Q1 revenue $3.6 billion versus I/B/E/S view $3.54 billion

* Qtrly loss per share from continuing operations $7.85

* Sees FY total net revenues $15,800 – $16,000 million

* Company raises full year 2017 guidance

* Sees FY net loss per share $9.70 - $10.20

* Sees FY research and development expense to be about $2.1 billion

* Sees 2017 non-GAAP net income per share $15.85 - $16.35

* FY2017 earnings per share view $16.05, revenue view $15.73 billion -- Thomson Reuters I/B/E/S

* Q1 earnings per share view $3.30 -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below